Navigation Links
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Date:3/20/2009

RIDGEFIELD, Conn., March 20 /PRNewswire/ -- Boehringer Ingelheim today announced that the last patient has completed treatment in the Phase III Randomized Evaluation of Long term Anticoagulant therapy (RE-LY(R)) study. This study compared the long-term efficacy and safety of the oral direct thrombin inhibitor dabigatran etexilate with the current standard therapy, warfarin (target international normalized ratio, INR, 2-3) for the prevention of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF). Dabigatran etexilate is an oral anticoagulant in Phase III development for stroke prevention in AF, as well as several other therapeutic areas. Dabigatran etexilate is not approved by the FDA. RE-LY(R) is the largest AF stroke prevention trial to date. The study enrolled 18,113 patients in more than 900 centers in 44 countries worldwide between December 2005 and December 2007. Data will now be analyzed and results are expected to be presented later this year at the European Society of Cardiology (ESC) Congress, taking place in Barcelona, Spain, from August 29th until September 2nd.

"We are delighted with the completion of treatment in the RE-LY study as it marks an important milestone in the ongoing development of dabigatran etexilate," said Paul Reilly, clinical program director, Boehringer Ingelheim. "We are grateful to the patients and investigators who participated in the study and look forward to further evaluating the safety and efficacy of dabigatran through the analysis of the data."

Atrial fibrillation affects more than 2.2 million Americans, making it the most common heart rhythm disorder in the U.S.(1) People with AF are at increased risk for forming blood clots in their hearts(2) which can raise their risk of stroke five-fold.(3) However, clinical studies show that up to 60 percent of AF related strokes can be prevented with appropriate anticoagulant therapy.(4) Vitamin K antagonists are the c
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Photos: Eight Finalists Lose 685 Pounds and Gain $800,000
2. Clinical Data from Plastic Surgeon in New Jersey Helped in Final Determination of 2008's Top Plastic Surgery Procedures
3. USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA(R)
4. Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
5. Nuvos High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist
6. EMPLOYER SURVEY - Final Opportunity to Participate in the UBA Employer Benefits Perspective Survey
7. Final Economic Stimulus Bill Permits Americans Personal Health Information to Be Sold for Research and Public Health Purposes WITHOUT Patients Consent
8. The NBA Teams up With Body By Milk to Challenge Teenagers to Get Fit By Finals
9. OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)
10. Samplify Systems SAM1600 Family of Analog/Digital Converters Named Finalist in EDN Magazines 19th Annual Innovation Awards
11. Final House Vote on SCHIP Delivers Peace of Mind to Americas Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 Isabel ... of Allied Health Professions (ASAHP) Conference on October 22-24 ... CEO will participate in a panel discussion on Technology ... , Isabel Healthcare provides a diagnostic decision support tool ... the diagnosis skills of students and clinical learners. The ...
(Date:10/22/2014)... Amy Norton HealthDay Reporter ... riveted on the three Ebola cases in Dallas. But, mental ... threat to Americans. President Barack Obama on Friday appointed ... virus, which has infected two Dallas nurses who cared for ... Texas Health Presbyterian Hospital. But the U.S. cases are ...
(Date:10/22/2014)... Shriners Hospitals for Children® and UK HealthCare have ... of Shriners Hospitals for Children - Lexington from 1900 ... of Kentucky Albert B. Chandler Hospital. The new facility ... operated by Shriners Hospitals for Children, and designed to ... families well into the future. , “The quality care ...
(Date:10/22/2014)... October 22, 2014 Hay House is pleased ... Addiction and Upgrade Your Life (Paperback; $10.82) written by the ... & Recovery. This book is meant to help readers ... life of recovery. , Recovery 2.0 is not the ... Recovery 2.0 is a guide for what comes next. ...
(Date:10/22/2014)... OR (PRWEB) October 22, 2014 During ... California’s fresh water supply runs dangerously low, Southern Oregon’s ... Southern Oregon’s rivers, despite the lowest mountain snow pack ... in late summer and early autumn.* That was the ... of the new book “Hiking Southern Oregon,” during an ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4
... Technology Awards Foundation Pays Tribute to Individuals ... Technology to Benefit Society, SAN DIEGO, June 3 ... that esteemed customer, Alliant Techsystems,(NYSE: ATK ), a ... billion in annual sales, has been recognized as a ...
... both HIV-infected and HIVuninfected men , Adult circumcision ... according to research published in PLoS Medicine. , ... the rural Rakai district of Uganda, Ron Gray of ... and colleagues found approximately a 3% rate of moderate ...
... MELVILLE, N.Y., June 2 Gentiva Health,Services, Inc. ... of,comprehensive home health services, announced today that it ... Colorado,s largest home health,providers, for $12 million in ... credit facility., PHHC, first established by a ...
... and bone degradation, progressive knee osteoarthritis (OA) is believed ... local mechanical factors. Lack of joint stability, poor ... tissue that cushion the knee all affect load distribution ... However, in studies of knee OA progression, either meniscal ...
... Pa., June 2 Philadelphia,Consolidated Holding Corp. (Nasdaq: ... for Home Health Care and Hospice services. Providing ... market, PHLY,s Home Health Care,and Hospice products offer ... Sexual Abuse and Molestation,Crime, and Umbrella., Eligible ...
... early psychotic symptoms, researchers say , , MONDAY, June 2 ... long time can develop abnormalities in their brains, Australian ... marijuana use is associated with a wide range of ... harmless and should be legalized, the researchers noted. , ...
Cached Medicine News:Health News:ATK Receives Laureate Award From Computerworld Honors Program for Storage and Data Protection Innovation Featuring Overland's Products 2Health News:ATK Receives Laureate Award From Computerworld Honors Program for Storage and Data Protection Innovation Featuring Overland's Products 3Health News:ATK Receives Laureate Award From Computerworld Honors Program for Storage and Data Protection Innovation Featuring Overland's Products 4Health News:Study finds circumcision safe in both HIV-infected and HIV-uninfected men 2Health News:Study finds circumcision safe in both HIV-infected and HIV-uninfected men 3Health News:Gentiva(R) Health Services Acquires Leading Colorado Home Health Provider 2Health News:Gentiva(R) Health Services Acquires Leading Colorado Home Health Provider 3Health News:Meniscal damage and joint malalignment predictors of cartilage loss 2Health News:Meniscal damage and joint malalignment predictors of cartilage loss 3Health News:Marijuana May Shrink Parts of the Brain 2Health News:Marijuana May Shrink Parts of the Brain 3
(Date:10/22/2014)... -- Investor-Edge has initiated coverage on the ... ), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX ), ... Pharmaceuticals Inc. (NASDAQ: IDRA ), and Merrimack ... companies can be accessed at: http://investor-edge.com/register . ... ended at 4,419.48, up 2.40%, the Dow Jones Industrial ...
(Date:10/22/2014)... N.J. , Oct. 22, 2014   ... a world-renowned leader in the field of infertility, ... approach to embryonic screening. The research abstract, released ... for Reproductive Medicine (ASRM) meeting in ... (CCS) and single gene defect (SGD) pre-implantation genetic ...
(Date:10/22/2014)... Oct. 22, 2014 AVACEN Medical announced today ... 510 (k) OTC clearance by the U.S. Food and ... be marketed over the Internet for: the temporary ... and minor strains and sprains . Logo ... 100 (MSRP $2495) is a sophisticated medical device incorporating ...
Breaking Medicine Technology:Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2
... organizations and individuals across the country and around the ... 1, 2007. Since 1988,World AIDS Day has provided countless ... reinvigorate global, national, regional,and local efforts to stop AIDS., ... Day is leadership. Nearly 27,years since it was first ...
... to Conduct Conference Call on, December 10, 2007 to Discuss ... ... Data, SOUTH SAN FRANCISCO, Calif., Nov. 29 Sunesis,Pharmaceuticals, Inc. ... today announced that it,will present data on the company,s two lead ...
Cached Medicine Technology:AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic 2Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology 2Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology 3
... sterile nonpyrogenic, transparent viscoelastic solution of highly ... of high molecular weight (greater than 1 ... saline. In the limit of zero shear ... Pa s) at 25C, and the osmolality ...
... Medmont DV2000 provides an integrated solution for ... a range of clinical instruments. Capture and ... exams or a video sequence. The explorer ... of patient results and direct access to ...
... With a test capability extending to ... of a patient's visual field, allowing peripheral ... central field to be explored. Practice Management ... your practice. With the Medmont Studio package ...
... The first Open Bore MR ,Siemens has ... 70 cm bore, a very short 125 cm ... create something very revolutionary: Open Bore MR. And ... imaging matrix). A unique Siemens technology, which means ...
Medicine Products: